Davutamig (REGN-5093) is a humanized IgG4-kappa anti-MET monoclonal antibody that targets two distinct, nonoverlapping epitopes on the MET receptor and functions as an antineoplastic agent [1].
CAS Number:
[2648058-48-2]
Target:
c-Met/HGFR
* VAT and and shipping costs not included. Errors and price changes excepted
